Vor Biopharma Announces $100 Million Public Offering of Common Stock

Cooley has advised Vor Biopharma. Paul Hastings LLP has advised J.P. Morgan, Jefferies, Citigroup, and TD Cowen. Vor Biopharma Inc. has announced the pricing of an…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Laura Testa

Author: Laura Testa

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here